Herein, this study uncovered a novel mechanism underlying BMI1 up-regulation and BMI1-mediated activation of P-GP in GC-chemoresistant bladder cancer, and represented this protein as a potential target for GC-chemoresistant patients with bladder cancer. Here, PGP is linked to urinary bladder cancer.